Intermittent fasting is often promoted as a method for weight loss and improving metabolic health. GLP-1 receptor agonists such as semaglutide or liraglutide are also specifically used for weight reduction. The obvious question, then, is: Can both approaches be combined – or is that overkill?
Why prolonged intermittent fasting is not recommended during GLP-1 therapy
Appetite is already significantly reduced during GLP-1 therapy. Combining this with long fasting intervals such as 16/8 or 5:2 increases the risk of insufficient energy and nutrient intake. The consequences can be:
- Increased side effects such as nausea, bloating or circulatory problems, because the stomach empties even more slowly.
- Insufficient energy and nutrient intake, which can lead to muscle wasting and persistent fatigue.
- Yo-yo effect after stopping the injection, because a large calorie deficit lowers the basal metabolic rate in the long term.
Regular meals – sometimes even more frequently throughout the day than usual – help to avoid these risks. They stabilize blood sugar, facilitate digestion, and ensure a balanced supply of energy and nutrients.
What is still advisable: 12 hours of overnight fasting
A nightly fast of approximately 12 hours (e.g., dinner at 7 p.m., breakfast at 7 a.m.) is recommended as a healthy foundation – even during GLP-1 therapy. Studies show that even such a moderate fasting window:
- which can improve insulin sensitivity
- Inflammatory markers decrease
- and supports metabolic flexibility.
This level of intermittent fasting is suitable for everyday life, safe and offers benefits without the risks of longer fasting periods.
Conclusion: Balance instead of extremes
While classic forms of intermittent fasting are not recommended in combination with GLP-1, a 12-hour overnight fast can certainly have positive effects. However, it is crucial to eat regularly and a balanced diet during the eating window.
- Sufficient protein for muscle maintenance
- complex carbohydrates for energy
- Healthy fats and fiber for satiety
- Micronutrients for metabolic health
This allows the effects of GLP-1 to be optimally supported without unnecessarily burdening the body or causing a deficiency.
Sources
- Patterson RE, Sears DD. Metabolic Effects of Intermittent Fasting. Annu Rev Nutr. 2017;37:371-393. PubMed
- Meier JJ, et al. Glucagon-like peptide 1 (GLP-1) infusion in healthy men during prolonged fasting does not cause reactive hypoglycemia. J Clin Endocrinol Metab. 2009;94(2): 618-25. PubMed
- Lundgren JR, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. Diabetologia. 2021;64:1775–1786. SpringerLink